FY 2025
Loading financial data...
|
Chart |
FY21
Dec 31, 2021
|
FY22
Dec 31, 2022
|
FY23
Dec 31, 2023
|
FY24
Dec 31, 2024
|
FY25
Dec 31, 2025
|
TTM
Trailing 12M
|
|---|---|---|---|---|---|---|---|
|
Revenue
Total sales generated. |
|
$287.60 B | $324.16 B | $371.62 B | $400.28 B | $447.57 B | $449.71 B |
|
Cost of Revenue Direct cost of goods/services. |
|
$217.95 B | $244.55 B | $280.66 B | $310.88 B | $364.65 B | $365.16 B |
Gross Profit Revenue minus cost of revenue. |
|
$69.65 B | $79.62 B | $90.96 B | $89.40 B | $82.92 B | $84.55 B |
|
Operating Expense
Costs to run business. 
|
|
$45.68 B | $51.18 B | $58.60 B | $57.11 B | $63.95 B | $65.72 B |
Operating Income Profit from operations. |
|
$23.97 B | $28.44 B | $32.36 B | $32.29 B | $18.96 B | $18.84 B |
|
Net Interest Income
Interest income minus expense.
|
|
-$1.66 B | -$2.09 B | -$3.25 B | -$3.91 B | -$4.00 B | -$3.96 B |
Non-Operating Income (ex-Int) Income outside core operations. |
|
- | - | - | $8.31 B | $265.00 M | $178.00 M |
Total Other Income (Net) Net non-operating items. |
|
-$1.66 B | -$2.09 B | -$3.25 B | -$12.22 B | -$4.27 B | -$4.28 B |
Income Before Tax Profit before taxes. |
|
$22.31 B | $26.34 B | $29.11 B | $20.07 B | $14.70 B | $14.55 B |
Income Tax Expense Taxes on income. |
|
$4.58 B | $5.70 B | $5.97 B | $4.83 B | -$280.00 M | $1.74 B |
|
Net Income
Final profit.
|
|
$17.29 B | $20.12 B | $22.38 B | $14.41 B | $14.23 B | $12.04 B |
|
Earnings Per Share
Company profit allocated to each outstanding share. |
|||||||
EPS Earnings per share. Formula: Net Income ÷ Shares |
|
$18.33 | $21.54 | $24.12 | $15.64 | $15.66 | $13.26 |
Diluted EPS EPS including dilution. Formula: Net Income ÷ Diluted Shares |
|
$18.08 | $21.18 | $23.86 | $15.51 | $15.58 | $13.24 |
|
Shares for EPS
Number of shares used to calculate EPS. |
|||||||
Weighted Average Shares Outst. Avg shares used for EPS. |
|
943.00 M | 934.00 M | 928.00 M | 929.00 M | 910.00 M | 910.00 M |
Diluted Average Shares Outst. Shares including dilution. |
|
956.00 M | 950.00 M | 938.00 M | 929.00 M | 910.00 M | 910.00 M |
| Supplemental Items | |||||||
EBIT Earnings before interest and tax. |
|
$23.97 B | $28.44 B | $32.36 B | $23.98 B | $18.70 B | $18.66 B |
EBITDA Earnings before interest, tax, D&A. |
|
$27.07 B | $31.84 B | $36.33 B | $28.08 B | $23.06 B | $22.99 B |
Depreciation and Amortization Non-cash expense for assets. |
|
$3.10 B | $3.40 B | $3.97 B | $4.10 B | $4.36 B | $4.33 B |
| Company Report |
FY 2025
UnitedHealth Group Incorporated's Balance Sheet
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading balance sheet when needed... |
UnitedHealth Group Incorporated's Cash flow
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading cash flow statement when needed... |
UnitedHealth Group Incorporated's Profitability
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading profitability metrics when needed... |
UnitedHealth Group Incorporated's Ratios
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
